Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 165

1.

Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.

Hornik CP, Yogev R, Mourani PM, Watt KM, Sullivan JE, Atz AM, Speicher D, Al-Uzri A, Adu-Darko M, Payne EH, Gelber CE, Lin S, Harper B, Melloni C, Cohen-Wolkowiez M, Gonzalez D; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee.

J Clin Pharmacol. 2019 Jul 17. doi: 10.1002/jcph.1499. [Epub ahead of print]

PMID:
31317556
2.

Cardiotoxicities of Modern Treatments in Breast Cancer.

Dent S, Melloni C, Ivars J, Sammons S, Kimmick G.

Curr Treat Options Cardiovasc Med. 2019 Jun 15;21(7):34. doi: 10.1007/s11936-019-0738-z. Review.

PMID:
31203459
3.

Unmet Needs in Managing Myocardial Infarction in Patients With Malignancy.

Inohara T, Endo A, Melloni C.

Front Cardiovasc Med. 2019 May 17;6:57. doi: 10.3389/fcvm.2019.00057. eCollection 2019. Review.

4.

Androgen deprivation therapy and cardiovascular disease.

Melloni C, Roe MT.

Urol Oncol. 2019 Mar 14. pii: S1078-1439(19)30065-1. doi: 10.1016/j.urolonc.2019.02.010. [Epub ahead of print] Review.

PMID:
30879969
5.

Systemic Timolol Exposure Following Topical Application to Infantile Hemangiomas.

Drolet BA, Boakye-Agyeman F, Harper B, Holland K, Lewandowski A, Stefanko N, Melloni C; Pediatric Trials Network Steering Committee.

J Am Acad Dermatol. 2019 Feb 18. pii: S0190-9622(19)30287-7. doi: 10.1016/j.jaad.2019.02.029. [Epub ahead of print] No abstract available.

PMID:
30790601
6.

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.

Fanaroff AC, Clare R, Pieper KS, Mahaffey KW, Melloni C, Green JB, Alexander JH, Jones WS, Harrison RW, Mehta RH, Povsic TJ, Moreira HG, Al-Khatib SM, Roe MT, Kong DF, Mathews R, Tricoci P, Holman RR, Wallentin L, Held C, Califf RM, Alexander KP, Lopes RD.

Circulation. 2019 Feb 12;139(7):863-873. doi: 10.1161/CIRCULATIONAHA.118.037202.

PMID:
30586739
7.

The Production of Clitic Pronouns: A Study on Bilingual and Monolingual Dyslexic Children.

Vender M, Hu S, Mantione F, Delfitto D, Melloni C.

Front Psychol. 2018 Nov 27;9:2301. doi: 10.3389/fpsyg.2018.02301. eCollection 2018.

8.

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.

Ungar L, Clare RM, Rodriguez F, Kolls BJ, Armstrong PW, Aylward P, Held C, Moliterno DJ, Strony J, Van de Werf F, Wallentin L, White HD, Tricoci P, Harrington RA, Mahaffey KW, Melloni C.

J Am Heart Assoc. 2018 Dec 18;7(24):e009609. doi: 10.1161/JAHA.118.009609.

9.

Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.

Chen ST, Melloni C.

J Am Coll Cardiol. 2018 Oct 16;72(16):1923-1925. doi: 10.1016/j.jacc.2018.07.078. No abstract available.

PMID:
30309469
10.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

PMID:
30291013
11.

Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF.

Chen ST, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Piccini JP, Singer DE, Patel MR, Melloni C.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):145-152. doi: 10.1093/ehjqcco/qcy040.

PMID:
30219887
12.

Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.

Hornik CP, Gonzalez D, van den Anker J, Atz AM, Yogev R, Poindexter BB, Ng KC, Delmore P, Harper BL, Melloni C, Lewandowski A, Gelber C, Cohen-Wolkowiez M, Lee JH; Pediatric Trial Network Steering Committee.

J Clin Pharmacol. 2018 Apr 20. doi: 10.1002/jcph.1116. [Epub ahead of print]

PMID:
29677389
13.

A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data.

Dallefeld SH, Atz AM, Yogev R, Sullivan JE, Al-Uzri A, Mendley SR, Laughon M, Hornik CP, Melloni C, Harper B, Lewandowski A, Mitchell J, Wu H, Green TP, Cohen-Wolkowiez M.

J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):419-430. doi: 10.1007/s10928-018-9576-y. Epub 2018 Feb 12.

14.

Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.

Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Blackford M, Yogev R, James LP, Melloni C, Harper B, Mitchell J, Benjamin DK Jr, Boakye-Agyeman F, Cohen-Wolkowiez M.

Ther Drug Monit. 2018 Feb;40(1):103-108. doi: 10.1097/FTD.0000000000000466.

15.

Inflectional morphology and dyslexia: Italian children's performance in a nonword pluralization task.

Vender M, Mantione F, Savazzi S, Delfitto D, Melloni C.

Ann Dyslexia. 2017 Oct;67(3):401-426. doi: 10.1007/s11881-017-0152-8. Epub 2017 Nov 13.

PMID:
29134481
16.

Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.

Autmizguine J, Melloni C, Hornik CP, Dallefeld S, Harper B, Yogev R, Sullivan JE, Atz AM, Al-Uzri A, Mendley S, Poindexter B, Mitchell J, Lewandowski A, Delmore P, Cohen-Wolkowiez M, Gonzalez D; the Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01813-17. doi: 10.1128/AAC.01813-17. Print 2018 Jan.

17.

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group.

N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.

18.

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.

Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR; ORBIT-AF Steering Committee.

Eur Heart J Qual Care Clin Outcomes. 2017 Jul 1;3(3):192-197. doi: 10.1093/ehjqcco/qcx004.

PMID:
28838088
19.

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.

Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, Hylek EM, Hanna M, Wallentin L, Gersh BJ, Douglas PS, Alexander JH, Lopes RD.

Am J Med. 2017 Dec;130(12):1440-1448.e1. doi: 10.1016/j.amjmed.2017.06.026. Epub 2017 Jul 21.

PMID:
28739198
20.

A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation.

Ericson JE, Zimmerman KO, Gonzalez D, Melloni C, Guptill JT, Hill KD, Wu H, Cohen-Wolkowiez M.

Ther Drug Monit. 2017 Feb;39(1):13-20. doi: 10.1097/FTD.0000000000000364. Review.

Supplemental Content

Loading ...
Support Center